Sterling Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,508
Closed -$1.07M 3230
2025
Q4
$1.07M Sell
10,508
-390
-4% -$31.3K 0.02% 620
2025
Q3
$596K Sell
10,898
-834
-7% -$41.7K 0.01% 857
2025
Q2
$623K Buy
11,732
+5,297
+82% +$269K 0.01% 811
2025
Q1
$279K Sell
6,435
-1,324
-17% -$67K ﹤0.01% 1116
2024
Q4
$436K Buy
7,759
+2,242
+41% +$140K 0.01% 991
2024
Q3
$376K Buy
+5,517
New +$311K ﹤0.01% 1022
2018
Q4
Sell
-50,649
Closed -$4M 870
2018
Q3
$4M Buy
50,649
+6,949
+16% +$453K 0.04% 280
2018
Q2
$2.61M Buy
43,700
+11,830
+37% +$637K 0.02% 345
2018
Q1
$1.28M Buy
+31,870
New +$1.55M 0.01% 535

Other funds holding EXAS

Sterling Capital Management's EXAS Position: Q1 2026 in Review

Sterling Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10,508 shares — an estimated $1.07M sold.

Sterling Capital Management first reported a position in EXAS in Q1 2018 and held it in 9 quarters. The position peaked at $4M in Q3 2018. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Sterling Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Sterling Capital Management sold 10,508 Exact Sciences shares in Q1 2026, an estimated $1.07M.
  • Sterling Capital Management first reported a position in Exact Sciences in Q1 2018 and held it in 9 quarters.
  • Sterling Capital Management's Exact Sciences position peaked at $4M in Q3 2018.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.